
Sign up to save your podcasts
Or
For over a decade after a large study showed a mortality benefit, this drug remained controversial. David and James look at the TXA saga.
For over a decade after a large study showed a mortality benefit, this drug remained controversial. David and James look at the TXA saga.
1,867 Listeners
535 Listeners
387 Listeners
100 Listeners
810 Listeners
85 Listeners
256 Listeners
554 Listeners
713 Listeners
257 Listeners
27 Listeners
156 Listeners
2 Listeners
236 Listeners
466 Listeners